BioEdge Research Labs, LLC has announced the immediate availability of Cartalax, a synthetic tripeptide research compound designed for laboratory research applications. The 20mg lyophilized reference material is now available for purchase by qualified research institutions and laboratories conducting peptide studies.
The research-grade Cartalax compound, chemically identified as Ala-Glu-Asp (AED), represents a resource for laboratories engaged in peptide research. The availability follows increased demand from research facilities requiring high-purity reference materials for their investigational studies. Each vial contains 20mg of lyophilized peptide manufactured in the United States through domestic lyophilization processes.
"The availability of research peptides with comprehensive testing protocols is essential for advancing scientific understanding in laboratory settings," said Dr. Michael Chen, Director of Research Operations at BioEdge Research Labs. "Our testing process includes seven different analytical methods, representing the most extensive testing protocol in the industry. No other supplier tests for more parameters than we do."
BioEdge Research Labs maintains quality standards for all research compounds through what the company describes as the industry's most comprehensive testing protocol. The Cartalax research peptide undergoes seven distinct testing methods including HPLC and LC-MS analysis to verify purity specifications, with certificates of analysis available through lot-number lookup on the testing laboratory's website. This seven-times testing protocol represents more analytical parameters than any other supplier in the research peptide industry.
The company has been recognized for its customer service and product quality, maintaining a high rating on Trustpilot with numerous mentions of customer service excellence. Manufacturing takes place in facilities that follow standardized production processes, providing researchers with consistency in the reference materials they use in their laboratory investigations.
"Research institutions require suppliers who understand the importance of batch-to-batch consistency and comprehensive documentation," noted Sarah Williams, Quality Assurance Manager at BioEdge Research Labs. "Every vial of our research peptides comes with complete analytical data from our seven-point testing protocol, allowing researchers to focus on their scientific objectives rather than material verification."
The Cartalax peptide is available for immediate shipment to qualified research facilities. Detailed product information, including purity specifications and analytical data, can be found at https://bioedgeresearchlabs.com/product/cartalax-20mg/.
BioEdge Research Labs, LLC specializes in providing high-purity research peptides and compounds to the scientific research community. The company maintains a comprehensive catalog of research-grade materials, all manufactured under strict quality control standards and verified through independent third-party testing using the industry's most extensive testing protocols. With domestic manufacturing and lyophilization capabilities, BioEdge Research Labs serves research institutions throughout the United States, supporting various laboratory research applications with reference materials.
Researchers can access comprehensive product documentation and place orders through the company's research portal at https://bioedgeresearchlabs.com.
All products referenced are for laboratory research use only. They are not intended for human or veterinary use, or for use in diagnostic procedures. These products have not been evaluated by the U.S. Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent any disease.
###
For more information about BioEdge Research Labs, LLC, contact the company here:
BioEdge Research Labs
BioEdge Research Labs
(307) 667-1404
info@bioedgeresearchlabs.com
1603 Capitol Ave.
Suite 413-D239,
Cheyenne, WY
